Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AnaptysBio Inc (NASDAQ: ANAB) closed the day trading at $13.22 up 1.38% from the previous closing price of $13.04. In other words, the price has increased by $1.38 from its previous closing price. On the day, 0.64 million shares were traded. ANAB stock price reached its highest trading level at $13.34 during the session, while it also had its lowest trading level at $12.51.
Ratios:
For a better understanding of ANAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.23 and its Current Ratio is at 10.23. In the meantime, Its Debt-to-Equity ratio is 4.35 whereas as Long-Term Debt/Eq ratio is at 4.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on December 11, 2024, Downgraded its rating to Neutral and sets its target price to $19 from $52 previously.
On July 22, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $55.H.C. Wainwright initiated its Buy rating on July 22, 2024, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 29 ’24 when RENTON HOLLINGS sold 10,000 shares for $25.00 per share. The transaction valued at 250,000 led to the insider holds 1,950 shares of the business.
HOLLINGS C RENTON bought 10,000 shares of ANAB for $250,000 on Nov 29 ’24. On Sep 23 ’24, another insider, Lizzul Paul F., who serves as the Chief Medical Officer of the company, sold 1,500 shares for $38.67 each. As a result, the insider received 58,005 and left with 15,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 402267424 and an Enterprise Value of 339208192. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.68 while its Price-to-Book (P/B) ratio in mrq is 4.77. Its current Enterprise Value per Revenue stands at 5.933 whereas that against EBITDA is -2.432.
Stock Price History:
Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $13.00. The 50-Day Moving Average of the stock is -39.82%, while the 200-Day Moving Average is calculated to be -51.19%.
Shares Statistics:
Over the past 3-months, ANAB traded about 573.40K shares per day on average, while over the past 10 days, ANAB traded about 627020 shares per day. A total of 30.43M shares are outstanding, with a floating share count of 26.01M. Insiders hold about 14.52% of the company’s shares, while institutions hold 103.68% stake in the company. Shares short for ANAB as of 1734048000 were 6985977 with a Short Ratio of 12.18, compared to 1731628800 on 6714227. Therefore, it implies a Short% of Shares Outstanding of 6985977 and a Short% of Float of 31.350002.
